about
A new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient miceOpportunities for the treatment of inflammation in cardiovascular diseasePRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ CostimulationPatients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjectsReduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells.First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.Fistular onion stalk extract exhibits anti-atherosclerotic effects in rats.Slit proteins, potential endogenous modulators of inflammation.Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation.Inflammation in coronary artery disease: potential role for immunomodulatory therapy.Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.Shear Stress Enhances Chemokine Secretion from Chlamydia pneumoniae-infected Monocytes.Tumor-like coronary atheroma: a modern coronary evaluation with a historical perspective.The duality of chemokines in heart failure.Atheroprotective effects of conjugated linoleic acid.Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice.Monocyte chemoattractant protein-1 gene polymorphism and its serum level have an impact on anthropometric and biochemical risk factors of metabolic syndrome in Indian population.Immunological aspects of atherosclerosis
P2860
Q27302261-A2D5A1DC-2091-4E7C-B008-F25C420704B8Q28192292-813659FB-9ED1-4CAA-9ADD-629434B2EEDBQ28550383-67DAFFFC-D0BC-4990-BEF6-EEB43DC0B691Q30318873-0F0B3223-33E7-4C3A-ACDA-E81D4F48801FQ33581032-7BB4FA08-2A14-4F1D-B92E-C316232F1117Q33809888-9CAFA666-C76C-4D20-9A67-AD6C09E6D6A6Q33962606-3C268CEA-79D3-4A14-B491-E755FEA0CAACQ35022576-6AF8F45B-C46C-4DF6-9281-148309258DB4Q35045007-6122A172-ED55-4CF6-8A89-9FECE5771C52Q36314881-F060D5A7-C31E-4AA7-925F-20AC2A249D84Q37536067-B8AB8E37-C39B-4FA6-9510-1B184BE8852EQ37844983-69F503BF-1107-47A1-8B13-F3697BE27673Q37896463-71AED301-ACBA-4F22-A484-884C6671A0EBQ38375149-191CDA9C-40DD-4EEA-AFD0-9C305FE93C4DQ38796198-CD67D938-9BE5-4DFF-AE0C-B41C0B095AF1Q42789241-DB10E014-E2B2-416D-AB1E-F9ED0FE45CD8Q51308595-F952E7C8-5E9D-47E6-9CC3-B39364580358Q58197587-710B621D-3B55-4898-A2F2-19062260A44F
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chemokines, leukocytes, and atherosclerosis.
@ast
Chemokines, leukocytes, and atherosclerosis.
@en
Chemokines, leukocytes, and atherosclerosis.
@nl
type
label
Chemokines, leukocytes, and atherosclerosis.
@ast
Chemokines, leukocytes, and atherosclerosis.
@en
Chemokines, leukocytes, and atherosclerosis.
@nl
prefLabel
Chemokines, leukocytes, and atherosclerosis.
@ast
Chemokines, leukocytes, and atherosclerosis.
@en
Chemokines, leukocytes, and atherosclerosis.
@nl
P2093
P356
P1476
Chemokines, leukocytes, and atherosclerosis.
@en
P2093
P356
10.1067/MLC.2000.108154
P577
2000-08-01T00:00:00Z